TrialCancer prevention research (Philadelphia, Pa.)2014

A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology.

Kenneth G Linden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.